Israel Englander Sorrento Therapeutics, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.74 - $1.83 $225,100 - $556,667	304,190 Added 69.48%	741,995 $657,000
Q3 2022 Nov 14, 2022	BUY	$1.51 - $2.88 $288,630 - $550,500	191,146 Added 77.49%	437,805 $687,000
Q2 2022 Aug 15, 2022	BUY	$1.24 - $2.33 $305,857 - $574,715	246,659 New	246,659 $496,000
Q1 2022 May 16, 2022	SELL	$2.0 - $4.9 $266,296 - $652,425	-133,148 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.65 - $7.23 $619,138 - $962,660	133,148 New	133,148 $619,000
Q3 2021 Nov 15, 2021	SELL	$7.41 - $10.99 $1.27 Million - $1.88 Million	-171,293 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$6.35 - $10.0 $1.39 Million - $2.18 Million	-218,169 Reduced 56.02%	171,293 $1.66 Million
Q1 2021 May 17, 2021	BUY	$7.03 - $16.51 $2.63 Million - $6.17 Million	373,960 Added 2412.33%	389,462 $3.22 Million
Q4 2020 Feb 16, 2021	SELL	$5.76 - $11.95 $3.3 Million - $6.85 Million	-573,174 Reduced 97.37%	15,502 $106,000
Q3 2020 Nov 16, 2020	BUY	$6.17 - $18.82 $3.12 Million - $9.51 Million	505,264 Added 605.74%	588,676 $6.56 Million
Q2 2020 Aug 14, 2020	SELL	$1.73 - $6.76 $9,828 - $38,403	-5,681 Reduced 6.38%	83,412 $524,000
Q1 2020 May 14, 2020	BUY	$1.57 - $4.76 $139,876 - $424,082	89,093 New	89,093 $164,000
Q4 2019 Feb 14, 2020	SELL	$1.45 - $4.17 $55,553 - $159,765	-38,313 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$2.05 - $2.69 $227,336 - $298,310	-110,896 Reduced 74.32%	38,313 $81,000
Q2 2019 Aug 15, 2019	BUY	$2.67 - $4.38 $386,995 - $634,845	144,942 Added 3396.81%	149,209 $398,000
Q2 2019 Aug 14, 2019	SELL	$2.67 - $4.38 $266,866 - $437,781	-99,950 Reduced 95.91%	4,267 $298,000
Q1 2019 May 14, 2019	BUY	$1.86 - $5.94 $193,843 - $619,048	104,217 New	104,217 $495,000
Q4 2018 Feb 14, 2019	SELL	$2.01 - $4.24 $38,927 - $82,116	-19,367 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$4.22 - $7.5 $1.03 Million - $1.84 Million	-245,241 Reduced 92.68%	19,367 $85,000
Q2 2018 Aug 14, 2018	SELL	$4.75 - $8.0 $5.56 Million - $9.36 Million	-1,170,062 Reduced 81.56%	264,608 $1.91 Million
Q1 2018 May 15, 2018	BUY	$4.5 - $9.95 $803,322 - $1.78 Million	178,516 Added 14.21%	1,434,670 $7.39 Million
Q4 2017 Feb 14, 2018	BUY	$1.75 - $3.8 $1.23 Million - $2.67 Million	703,505 Added 127.3%	1,256,154 $4.77 Million
Q3 2017 Nov 14, 2017	BUY	$1.63 - $2.0 $900,817 - $1.11 Million	552,649	552,649 $940,000

Others Institutions Holding SRNE

# of Institutions

Shares Held

5.47M

Call Options Held

Put Options Held

View Full List

About Sorrento Therapeutics, Inc.

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

More about SRNE

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account